US Patent Issued to PLEIOGENIX on March 25 for "Methods of treating fibrotic liver diseases or conditions with indeglitazar" (Missouri, California Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,234, issued on March 25, was assigned to PLEIOGENIX INC. (Carlsbad, Calif.).

"Methods of treating fibrotic liver diseases or conditions with indeglitazar" was invented by Prasad Manchem (Carlsbad, Calif.) and Joseph L. Evans (Saint Louis, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating alcoholic hepatitis in a subject, comprising administering to the subject a therapeutically effective amount of indeglitazar or a pharmaceutically acceptable salt thereof."

The patent was filed on July 12, 2024, under Application No. 18/771,595.

*For further information, including images, charts and tables, pl...